These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6789682)

  • 1. I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.
    Nelson M; Nelson DS; Hopper KE
    Am J Pathol; 1981 Aug; 104(2):114-24. PubMed ID: 6789682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
    Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
    Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to relate the anti-tumour action of cyclophosphamide with the immunogenicity of two murine fibrosarcomas.
    Evans R
    Int J Cancer; 1978 May; 21(5):611-6. PubMed ID: 659026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of resistance of mice to syngeneic methylcholanthrene induced fibrosarcomas.
    Nelson DS; Nelson M; Hopper KE
    Adv Exp Med Biol; 1979; 121B():541-52. PubMed ID: 232623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas.
    Wood GW; Gillespie GY
    Int J Cancer; 1975 Dec; 16(6):1022-9. PubMed ID: 1201871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
    Hopper KE; Harrison J; Nelson DS
    J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
    Ray PK; Raychaudhuri S
    J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas.
    Pross HF; Kerbel RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1157-67. PubMed ID: 1087351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I.
    Hopper KE; Cahill JM
    J Reticuloendothel Soc; 1983 Jun; 33(6):443-56. PubMed ID: 6602218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. II. Tumor growth at sites of inflammation induced by mitogens in mice.
    Nelson M; Nelson DS
    Am J Pathol; 1981 Aug; 104(2):125-31. PubMed ID: 7258299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory cell activity of murine tumor-associated macrophages.
    Dougherty GJ; McBride WH
    J Natl Cancer Inst; 1986 Mar; 76(3):541-8. PubMed ID: 3512894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological consequences of tumor excision: from active immunity to immunological memory.
    Bursuker I; North RJ
    Int J Cancer; 1986 Feb; 37(2):275-81. PubMed ID: 3943923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
    Nelson M; Nelson DS
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adoptive transfer of concomitant immunity to murine tumor isografts with spleen cells from tumor-bearing animals.
    Deckers PJ; Edgerton BW; Thomas BS; Pilch YH
    Cancer Res; 1971 Jun; 31(6):734-42. PubMed ID: 5088484
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of modifiers of natural biological response on the functional activity of macrophages (oncological aspect)].
    Gromov SA; Voĭtenkov BO; Okulov VB
    Antibiot Khimioter; 1990 Feb; 35(2):29-33. PubMed ID: 2337372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.